Histone deacetylase 11 as a key regulator of metabolism and obesity

In this thought commentary, I highlight the discoveries made by Seto and colleagues related to HDAC11 and obesity. I discuss how their reported work fills a gap in the HDAC field and comment on the clinical implications of their findings. Overall, selective inhibition of HDAC11 could be a novel pote...

Descripción completa

Detalles Bibliográficos
Autor principal: Bhaskara, Srividya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154867/
https://www.ncbi.nlm.nih.gov/pubmed/30126820
http://dx.doi.org/10.1016/j.ebiom.2018.08.008
_version_ 1783357774919368704
author Bhaskara, Srividya
author_facet Bhaskara, Srividya
author_sort Bhaskara, Srividya
collection PubMed
description In this thought commentary, I highlight the discoveries made by Seto and colleagues related to HDAC11 and obesity. I discuss how their reported work fills a gap in the HDAC field and comment on the clinical implications of their findings. Overall, selective inhibition of HDAC11 could be a novel potential therapeutic avenue for both obesity and diabesity, the diabetes caused by obesity. Future studies to further dissect this mechanistic link between HDAC11 and metabolic programs will pave the way for designing mechanism-based combination therapeutic strategies for these two life style diseases.
format Online
Article
Text
id pubmed-6154867
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61548672018-09-26 Histone deacetylase 11 as a key regulator of metabolism and obesity Bhaskara, Srividya EBioMedicine Commentary In this thought commentary, I highlight the discoveries made by Seto and colleagues related to HDAC11 and obesity. I discuss how their reported work fills a gap in the HDAC field and comment on the clinical implications of their findings. Overall, selective inhibition of HDAC11 could be a novel potential therapeutic avenue for both obesity and diabesity, the diabetes caused by obesity. Future studies to further dissect this mechanistic link between HDAC11 and metabolic programs will pave the way for designing mechanism-based combination therapeutic strategies for these two life style diseases. Elsevier 2018-08-17 /pmc/articles/PMC6154867/ /pubmed/30126820 http://dx.doi.org/10.1016/j.ebiom.2018.08.008 Text en © 2018 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Bhaskara, Srividya
Histone deacetylase 11 as a key regulator of metabolism and obesity
title Histone deacetylase 11 as a key regulator of metabolism and obesity
title_full Histone deacetylase 11 as a key regulator of metabolism and obesity
title_fullStr Histone deacetylase 11 as a key regulator of metabolism and obesity
title_full_unstemmed Histone deacetylase 11 as a key regulator of metabolism and obesity
title_short Histone deacetylase 11 as a key regulator of metabolism and obesity
title_sort histone deacetylase 11 as a key regulator of metabolism and obesity
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154867/
https://www.ncbi.nlm.nih.gov/pubmed/30126820
http://dx.doi.org/10.1016/j.ebiom.2018.08.008
work_keys_str_mv AT bhaskarasrividya histonedeacetylase11asakeyregulatorofmetabolismandobesity

Ejemplares similares